Captrust Financial Advisors Novo Nordisk A S Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

A detailed history of Captrust Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Captrust Financial Advisors holds 155,212 shares of NVO stock, worth $13.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
155,212
Previous 160,823 3.49%
Holding current value
$13.6 Million
Previous $23 Million 19.49%
% of portfolio
0.06%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $668,101 - $815,951
-5,611 Reduced 3.49%
155,212 $18.5 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $1.35 Million - $1.62 Million
10,997 Added 7.34%
160,823 $23 Million
Q1 2024

May 15, 2024
BUY
$102.11 - $135.92 $505,138 - $672,396
4,947 Added 3.41%
149,826 $19.2 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $3.01 Million - $3.61 Million
34,278 Added 30.99%
144,879 $15 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $6.32 Million - $13.9 Million
69,481 Added 168.97%
110,601 $10.1 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $199,966 - $221,337
1,282 Added 3.22%
41,120 $6.65 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $578,325 - $695,441
4,370 Added 12.32%
39,838 $6.34 Million
Q4 2022

Feb 15, 2023
BUY
$102.55 - $135.33 $358,617 - $473,249
3,497 Added 10.94%
35,468 $4.8 Million
Q3 2022

Nov 16, 2022
BUY
$95.28 - $116.93 $684,777 - $840,375
7,187 Added 29.0%
31,971 $3.19 Million
Q2 2022

Aug 23, 2022
SELL
$103.24 - $121.81 $372,593 - $439,612
-3,609 Reduced 12.71%
24,784 $2.76 Million
Q2 2022

Aug 16, 2022
BUY
$103.24 - $121.81 $695,011 - $820,024
6,732 Added 31.08%
28,393 $3.16 Million
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $272,689 - $329,629
2,929 Added 15.64%
21,661 $2.43 Million
Q4 2021

Feb 14, 2022
BUY
$95.88 - $117.08 $575,280 - $702,480
6,000 Added 47.13%
18,732 $2.1 Million
Q3 2021

Nov 16, 2021
BUY
$84.42 - $106.62 $11,565 - $14,606
137 Added 1.09%
12,732 $1.22 Million
Q2 2021

Aug 16, 2021
BUY
$67.66 - $84.76 $51,827 - $64,926
766 Added 6.48%
12,595 $1.06 Million
Q1 2021

May 17, 2021
BUY
$67.06 - $75.82 $54,586 - $61,717
814 Added 7.39%
11,829 $808,000
Q4 2020

Feb 16, 2021
SELL
$63.89 - $73.8 $137,363 - $158,670
-2,150 Reduced 16.33%
11,015 $769,000
Q3 2020

Nov 17, 2020
BUY
$63.69 - $70.22 $99,547 - $109,753
1,563 Added 13.47%
13,165 $912,000
Q2 2020

Aug 14, 2020
BUY
$58.54 - $67.94 $173,044 - $200,830
2,956 Added 34.19%
11,602 $762,000
Q1 2020

May 15, 2020
BUY
$49.46 - $64.78 $6,578 - $8,615
133 Added 1.56%
8,646 $523,000
Q4 2019

Feb 14, 2020
BUY
$49.86 - $58.26 $424,458 - $495,967
8,513 New
8,513 $497,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email